Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,366 | 503 | 56.1% |
| Honoraria | $5,300 | 2 | 26.2% |
| Consulting Fee | $1,545 | 1 | 7.6% |
| Long term medical supply or device loan | $1,531 | 17 | 7.6% |
| Education | $343.23 | 6 | 1.7% |
| Travel and Lodging | $171.72 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Laboratory Corporation of America Holdings | $3,294 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $2,702 | 71 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $2,366 | 40 | $0 (2024) |
| Pharmacosmos Therapeutics Inc. | $2,350 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $674.97 | 19 | $0 (2024) |
| Merck Sharp & Dohme LLC | $611.16 | 34 | $0 (2024) |
| PFIZER INC. | $592.50 | 33 | $0 (2024) |
| Janssen Biotech, Inc. | $489.81 | 17 | $0 (2024) |
| Astellas Pharma US Inc | $389.84 | 15 | $0 (2024) |
| Eisai Inc. | $385.75 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,616 | 115 | PFIZER INC. ($221.46) |
| 2023 | $2,441 | 105 | Novartis Pharmaceuticals Corporation ($338.10) |
| 2022 | $5,791 | 119 | Laboratory Corporation of America Holdings ($3,294) |
| 2021 | $6,662 | 110 | Pharmacosmos Therapeutics Inc. ($2,300) |
| 2020 | $737.07 | 37 | Novartis Pharmaceuticals Corporation ($85.74) |
| 2019 | $719.54 | 21 | Alexion Pharmaceuticals, Inc. ($215.13) |
| 2018 | $726.39 | 16 | AstraZeneca Pharmaceuticals LP ($223.89) |
| 2017 | $564.22 | 7 | E.R. Squibb & Sons, L.L.C. ($181.53) |
All Payment Transactions
530 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Bone Health | ||||||
| 11/12/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Oncology | ||||||
| 10/31/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $74.99 | General |
| 10/30/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: Oncology | ||||||
| 10/25/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: CELLT | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $25.60 | General |
| Category: Hematology/Oncology | ||||||
| 10/15/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/08/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $17.50 | General |
| Category: Hematology | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $31.65 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $15.75 | General |
| Category: Hematology | ||||||
| 10/04/2024 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 2,968 | 18,206 | $740,089 | $252,262 |
| 2022 | 45 | 2,529 | 20,681 | $821,630 | $249,812 |
| 2021 | 47 | 2,048 | 36,339 | $645,923 | $214,571 |
| 2020 | 6 | 130 | 176 | $21,711 | $9,399 |
All Medicare Procedures & Services
145 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 27 | 3,000 | $126,360 | $49,841 | 39.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 17 | 2,221 | $82,362 | $40,720 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 175 | 409 | $78,549 | $36,800 | 46.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 52 | 187 | $48,061 | $25,232 | 52.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 28 | 125 | $43,251 | $12,007 | 27.8% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 77 | 496 | $74,400 | $10,650 | 14.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 54 | 54 | $19,760 | $8,426 | 42.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 230 | 602 | $18,186 | $6,221 | 34.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 73 | 123 | $16,473 | $5,746 | 34.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 239 | 687 | $19,092 | $5,201 | 27.2% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 29 | 32 | $20,800 | $4,956 | 23.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 222 | 513 | $4,001 | $3,912 | 97.8% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 163 | 267 | $13,003 | $3,555 | 27.3% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 64 | 378 | $12,561 | $3,419 | 27.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $8,854 | $3,377 | 38.1% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 137 | 189 | $10,181 | $2,780 | 27.3% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 14 | 129 | $15,480 | $2,733 | 17.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 68 | 272 | $13,872 | $2,718 | 19.6% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 24 | 164 | $10,168 | $2,481 | 24.4% |
| 83550 | Iron binding capacity | Office | 2023 | 148 | 234 | $7,313 | $1,997 | 27.3% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 11 | 79 | $12,008 | $1,912 | 15.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $4,995 | $1,880 | 37.6% |
| 82378 | Carcinoembryonic antigen (cea) protein level | Office | 2023 | 45 | 86 | $5,832 | $1,598 | 27.4% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 148 | 254 | $5,481 | $1,498 | 27.3% |
| 83540 | Iron level | Office | 2023 | 148 | 233 | $5,392 | $1,471 | 27.3% |
About Poras Patel
Poras Patel is a Internal Medicine healthcare provider based in Huntersville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/22/2014. The National Provider Identifier (NPI) number assigned to this provider is 1669876447.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Poras Patel has received a total of $20,257 in payments from pharmaceutical and medical device companies, with $2,616 received in 2024. These payments were reported across 530 transactions from 74 companies. The most common payment nature is "Food and Beverage" ($11,366).
As a Medicare-enrolled provider, Patel has provided services to 7,675 Medicare beneficiaries, totaling 75,402 services with total Medicare billing of $726,044. Data is available for 4 years (2020–2023), covering 145 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Medical Oncology, Hematology & Oncology
- Location Huntersville, NC
- Active Since 10/22/2014
- Last Updated 08/27/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1669876447
Products in Payments
- PGDX ELIO TISSUE COMPLETE (Device) $3,294
- Monoferric (Drug) $2,300
- KISQALI (Drug) $1,753
- OPDIVO (Biological) $548.38
- KEYTRUDA (Biological) $542.21
- Lenvima (Drug) $323.56
- LYNPARZA (Drug) $243.52
- ULTOMIRIS (Drug) $215.13
- VERZENIO (Drug) $213.48
- MEKINIST (Drug) $176.15
- CABOMETYX (Drug) $173.67
- PROMACTA (Drug) $171.71
- IBRANCE (Drug) $149.58
- XTANDI (Drug) $148.79
- NINLARO (Drug) $144.54
- IMBRUVICA (Drug) $143.93
- BOSULIF (Drug) $137.41
- VENCLEXTA (Drug) $129.36
- Pomalyst (Drug) $126.62
- Revlimid (Drug) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Huntersville
Alexis Smith, D.o, D.O
Internal Medicine — Payments: $492,236
Glen Kowalchuk, Md, MD
Internal Medicine — Payments: $93,721
William Hoover, Md, MD
Internal Medicine — Payments: $33,144
Dr. William Mitchell, Md, MD
Internal Medicine — Payments: $31,201
Jennifer Dallas, Md, MD
Internal Medicine — Payments: $17,309
Dr. Stacy Le, M.d, M.D
Internal Medicine — Payments: $13,752